Physical activity maintenance among young adult cancer survivors in an mHealth intervention: Twelve-month outcomes from the IMPACT randomized controlled trial.
activity tracker
cancer survivors
digital health
intervention
mHealth
maintenance
physical activity
social media
young adults
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
revised:
25
05
2023
received:
19
01
2023
accepted:
02
06
2023
medline:
1
9
2023
pubmed:
15
6
2023
entrez:
15
6
2023
Statut:
ppublish
Résumé
Most physical activity (PA) interventions in young adult cancer survivors (YACS) have focused on short-term outcomes without evaluating longer-term outcomes and PA maintenance. This study examined the effects of an mHealth PA intervention at 12 months, after 6 months of tapered contacts, relative to a self-help group among 280 YACS. YACS participated in a 12-month randomized trial that compared self-help and intervention groups. All participants received an activity tracker, smart scale, individual videochat session, and access to a condition-specific Facebook group. Intervention participants also received lessons, tailored feedback, adaptive goal setting, text messages, and Facebook prompts for 6 months, followed by tapered contacts. Accelerometer-measured and self-reported PA (total [primary outcome], moderate-to-vigorous [MVPA], light, steps, sedentary behaviors) were collected at baseline, 6, and 12 months. Generalized estimating equation analyses evaluated group effects on outcomes from baseline to 12 months. From baseline to 12 months, there were no between- or within-group differences in accelerometer-measured total PA min/week, while increases in self-reported total PA were greater in the intervention versus self-help group (mean difference = +55.8 min/week [95% CI, 6.0-105.6], p = 0.028). Over 12 months, both groups increased accelerometer-measured MVPA (intervention: +22.5 min/week [95% CI, 8.8-36.2] vs. self-help: +13.9 min/week [95% CI, 3.0-24.9]; p = 0.34), with no between-group differences. Both groups maintained accelerometer-measured and self-reported PA (total, MVPA) from 6 to 12 months. At 12 months, more intervention participants reported meeting national PA guidelines than self-help participants (47.9% vs. 33.1%, RR = 1.45, p = 0.02). The intervention was not more effective than the self-help group at increasing accelerometer-measured total PA over 12 months. Both groups maintained PA from 6 to 12 months. Digital approaches have potential for promoting sustained PA participation in YACS, but additional research is needed to identify what strategies work for whom, and under what conditions.
Sections du résumé
BACKGROUND
Most physical activity (PA) interventions in young adult cancer survivors (YACS) have focused on short-term outcomes without evaluating longer-term outcomes and PA maintenance. This study examined the effects of an mHealth PA intervention at 12 months, after 6 months of tapered contacts, relative to a self-help group among 280 YACS.
METHODS
YACS participated in a 12-month randomized trial that compared self-help and intervention groups. All participants received an activity tracker, smart scale, individual videochat session, and access to a condition-specific Facebook group. Intervention participants also received lessons, tailored feedback, adaptive goal setting, text messages, and Facebook prompts for 6 months, followed by tapered contacts. Accelerometer-measured and self-reported PA (total [primary outcome], moderate-to-vigorous [MVPA], light, steps, sedentary behaviors) were collected at baseline, 6, and 12 months. Generalized estimating equation analyses evaluated group effects on outcomes from baseline to 12 months.
RESULTS
From baseline to 12 months, there were no between- or within-group differences in accelerometer-measured total PA min/week, while increases in self-reported total PA were greater in the intervention versus self-help group (mean difference = +55.8 min/week [95% CI, 6.0-105.6], p = 0.028). Over 12 months, both groups increased accelerometer-measured MVPA (intervention: +22.5 min/week [95% CI, 8.8-36.2] vs. self-help: +13.9 min/week [95% CI, 3.0-24.9]; p = 0.34), with no between-group differences. Both groups maintained accelerometer-measured and self-reported PA (total, MVPA) from 6 to 12 months. At 12 months, more intervention participants reported meeting national PA guidelines than self-help participants (47.9% vs. 33.1%, RR = 1.45, p = 0.02).
CONCLUSION
The intervention was not more effective than the self-help group at increasing accelerometer-measured total PA over 12 months. Both groups maintained PA from 6 to 12 months. Digital approaches have potential for promoting sustained PA participation in YACS, but additional research is needed to identify what strategies work for whom, and under what conditions.
Identifiants
pubmed: 37317660
doi: 10.1002/cam4.6238
pmc: PMC10469755
doi:
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
16502-16516Subventions
Organisme : NCI NIH HHS
ID : R01 CA204965
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016086
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK056350
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002489
Pays : United States
Informations de copyright
© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
J Cancer Surviv. 2023 Feb 1;:
pubmed: 36723801
Can J Public Health. 1986 Sep-Oct;77(5):359-62
pubmed: 3791117
J Clin Oncol. 2016 May 10;34(14):1626-33
pubmed: 26951318
Med Sci Sports Exerc. 2012 Oct;44(10):2009-16
pubmed: 22525772
J Natl Cancer Inst. 2018 Nov 1;110(11):1190-1200
pubmed: 30299508
Contemp Clin Trials. 2021 Apr;103:106293
pubmed: 33515784
J Behav Med. 2011 Feb;34(1):41-52
pubmed: 20683649
Health Psychol. 2015 May;34(5):463-72
pubmed: 25110844
Ann Behav Med. 2022 Aug 2;56(8):842-855
pubmed: 34436552
J Am Coll Cardiol. 2019 Apr 30;73(16):2073-2075
pubmed: 31023431
BMC Cancer. 2021 Nov 25;21(1):1272
pubmed: 34823494
J Cancer Surviv. 2014 Dec;8(4):697-706
pubmed: 25103605
J Adolesc Young Adult Oncol. 2015 Dec;4(4):184-91
pubmed: 26697268
Int J Behav Nutr Phys Act. 2017 Feb 10;14(1):19
pubmed: 28187725
Am J Prev Med. 2018 Sep;55(3):395-402
pubmed: 30122216
Cancer. 2019 Aug 15;125(16):2856-2860
pubmed: 31012968
Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390
pubmed: 31626055
Res Q Exerc Sport. 2009 Jun;80(2):355-62
pubmed: 19650401
Cancer. 2013 Jan 1;119(1):201-14
pubmed: 22744865
J Cancer Surviv. 2023 Jun;17(3):569-594
pubmed: 37074621
Can J Appl Sport Sci. 1985 Sep;10(3):141-6
pubmed: 4053261
Support Care Cancer. 2021 Jul;29(7):4113-4127
pubmed: 33409722
Med Sci Sports Exerc. 2008 Jan;40(1):181-8
pubmed: 18091006
J Clin Oncol. 2013 Jun 20;31(18):2313-21
pubmed: 23690410
Int J Behav Nutr Phys Act. 2021 Apr 6;18(1):50
pubmed: 33823832
J Cancer Surviv. 2020 Feb;14(1):80-88
pubmed: 31776849
Cancer. 2012 Oct 1;118(19):4884-91
pubmed: 22688896
BMJ Open. 2020 Oct 29;10(10):e037136
pubmed: 33122311
Med Sci Sports Exerc. 2016 Aug;48(8):1514-1522
pubmed: 27031744
J Adolesc Young Adult Oncol. 2017 Jun;6(2):367-371
pubmed: 27845844
Med Sci Sports Exerc. 2015 Dec;47(12):2493-503
pubmed: 25970666
Annu Rev Psychol. 2001;52:1-26
pubmed: 11148297
Cancer. 2023 Feb 1;129(3):461-472
pubmed: 36444676
Cancer Med. 2023 Aug;12(15):16502-16516
pubmed: 37317660
Int J Behav Nutr Phys Act. 2019 Apr 27;16(1):37
pubmed: 31029140
J Sci Med Sport. 2021 Sep;24(9):902-907
pubmed: 34016536
Int J Behav Nutr Phys Act. 2014 Jul 02;11:80
pubmed: 24989069
JMIR Cancer. 2021 Apr 12;7(2):e24828
pubmed: 33843595
J Racial Ethn Health Disparities. 2017 Dec;4(6):1138-1146
pubmed: 28078657
Gait Posture. 2016 Feb;44:23-8
pubmed: 27004628
PLoS One. 2015 Mar 27;10(3):e0120996
pubmed: 25815479
Psychooncology. 2005 Jun;14(6):464-77
pubmed: 15484202
JCO Clin Cancer Inform. 2018 Dec;2:1-15
pubmed: 30652583
J Am Coll Cardiol. 2019 Apr 30;73(16):2062-2072
pubmed: 31023430
J Phys Act Health. 2017 Jul;14(7):539-545
pubmed: 28290761
Trials. 2022 Apr 4;23(1):254
pubmed: 35379294
J Cancer Surviv. 2013 Sep;7(3):355-68
pubmed: 23532799
J Clin Oncol. 2007 Jul 1;25(19):2709-18
pubmed: 17602076
JMIR Cancer. 2019 Jul 31;5(2):e12071
pubmed: 31368438
Cancer. 2022 Mar 1;128(5):1122-1132
pubmed: 34812521
J Adolesc Young Adult Oncol. 2017 Jun;6(2):318-326
pubmed: 28165844
J Cancer Surviv. 2016 Apr;10(2):280-90
pubmed: 26248766
Cancer Treat Rev. 2017 Apr;55:57-70
pubmed: 28340450
Psychooncology. 2013 Jan;22(1):54-64
pubmed: 21905158
Am J Health Behav. 2003 May-Jun;27(3):246-56
pubmed: 12751621
Am J Health Behav. 2017 Nov 1;41(6):784-795
pubmed: 29025506
JMIR Mhealth Uhealth. 2022 Jun 30;10(6):e37086
pubmed: 35771607
J Phys Act Health. 2010 Nov;7(6):697-705
pubmed: 21088299
Support Care Cancer. 2016 Dec;24(12):4861-4870
pubmed: 27435322
Cancer Med. 2022 Dec;11(23):4602-4611
pubmed: 35620805
J Cancer Surviv. 2013 Mar;7(1):74-82
pubmed: 23179496
J Cancer Surviv. 2015 Dec;9(4):660-82
pubmed: 25757733